+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Teleperformance SE (TEP) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 37 Pages
  • August 2026
  • GlobalData
  • ID: 1323185
Teleperformance SE (TEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teleperformance SE (Teleperformance) is a provider of digital business services. The company offers customer care, technical support, consulting and analytics, market research, digital integrated business services and other high-value specialized services. It also provides claims management, interpretation and translation, collection services, recruitment process outsourcing, visa and consular services and healthcare support services. The company offers its services through ZP Better Together, TLScontact, AllianceOne, Health Advocate, Intelenet, Majorel, LanguageLine Solutions, and PSG Global Solutions. Teleperformance serves governments, banking, financial services and insurance, healthcare, retail, energy, travel and hospitality, transportation, social media, entertainment, gaming, technology and telecommunications industries. It has business presence across the world. Teleperformance is headquartered in Paris, Ile-de-France, France.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Vetoquinol SA - Key Facts
  • Vetoquinol SA - Key Employees
  • Vetoquinol SA - Key Employee Biographies
  • Vetoquinol SA - Major Products and Services
  • Vetoquinol SA - History
  • Vetoquinol SA - Company Statement
  • Vetoquinol SA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Vetoquinol SA - Business Description
  • Other Break-up: Livestock
  • Performance
  • Other Break-up: Pets
  • Performance
  • Geographical Segment: Americas (Excluding USA)
  • Performance
  • Geographical Segment: Asia Pacific (Rest of World)
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: USA
  • Performance
  • R&D Overview
  • Vetoquinol SA - Corporate Strategy
  • Vetoquinol SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Vetoquinol SA - Strengths
  • Vetoquinol SA - Weaknesses
  • Vetoquinol SA - Opportunities
  • Vetoquinol SA - Threats
  • Vetoquinol SA - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Vetoquinol SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Vetoquinol SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Vetoquinol SA, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 12, 2026: Partnerships With Vetoquinol
  • Jun 12, 2026: Vetoquinol Sales Third Quarter 2023
  • Apr 28, 2026: Vetoquinol Reports First Quarter 2026 Sales
  • Mar 27, 2026: Vetoquinol Annual Results 2025
  • Nov 26, 2025: Vetoquinol USA, Inc. Recalls Six Lots of Folltropin Injectable Kits for Cattle Due to Particulate Matter in Diluent Vials
  • Nov 14, 2025: Batch Recall Alert - Folltropin 700 IU Powder and Solvent for Injection
  • Sep 11, 2025: Vetoquinol Announces 2025 Half Year Results
  • Mar 20, 2025: Vetoquinol Releases Annual Results 2024
  • Jan 30, 2025: Vetoquinol: Annual Sales 2024
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Vetoquinol SA, Key Facts
  • Vetoquinol SA, Key Employees
  • Vetoquinol SA, Key Employee Biographies
  • Vetoquinol SA, Major Products and Services
  • Vetoquinol SA, History
  • Vetoquinol SA, Subsidiaries
  • Vetoquinol SA, Key Competitors
  • Vetoquinol SA, Ratios based on current share price
  • Vetoquinol SA, Annual Ratios
  • Vetoquinol SA, Interim Ratios
  • Vetoquinol SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Vetoquinol SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Vetoquinol SA, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Vetoquinol SA, Performance Chart (2021 - 2025)
  • Vetoquinol SA, Ratio Charts
  • Vetoquinol SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Vetoquinol SA, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026